You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Juvenile idiopathic arthritis: Can you recognize this complex diagnosis?

Isennock, Melissa MPAS, PA‐C; Grosel, John M. MD

Journal of the American Academy of Physician Assistants:
Articles
Abstract

The variable manifestations of JIA make diagnosing it a considerable challenge for clinicians, but early, individualized treatment can decrease the long‐term sequelae of the disease.

Author Information

Melissa Isennock was a student in the Marietta College Pa program when this article was written. John Grosel is an assistant professor in the Marietta Pa program and a staff radiologist for Marietta Imaging, Inc, Marietta, Ohio. The authors have indicated no relationships to disclose relating to the content of this article.

DRUGS MENTIONED

Adalimumab (Humira)

Anakinra (Kineret)

Celecoxib (Celebrex)

Etanercept (Enbrel)

Infliximab (Remicade)

Leflunomide (Arava, generics)

Methotrexate (Rheumatrex, Trexall, generics)

Sulfasalazine (Azulfidine, Azulfidine EN‐tabs, generics)

Triamcinolone hexacetonide injection (Aristospan)

© 2011 Lippincott Williams & Wilkins, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.